[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Truist initiates Madrigal Pharmaceuticals at Buy with a $XXX price target, fueling acquisition speculation and positive sentiment. The stock is experiencing a slight price decline, likely due to profit-taking. ### About Madrigal Pharmaceuticals, Inc. Common Stock Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a biopharmaceutical company focused on therapeutics for non-alcoholic steatohepatitis (NASH). Madrigal Pharmaceuticals, Inc. Common Stock uses the ticker $MDGL for trading. Listed in the [Stocks](/list/stocks) and category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights [#](/topic/$mdgl/insights) - Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) social dominance is up XXXXXX% from the previous week. - Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) galaxy score™ is up XXXXX% from the previous week. - Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) sentiment is up XXXXX% from the previous week. ### Price: $XXXXXX [#](/topic/$mdgl/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/close.tsv) The current price decline to $XXXXXX is likely due to profit-taking, despite positive sentiment and strong social engagement driven by acquisition rumors and positive news, as the stock is up XXXX% in the last XX hours. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | -XXXX% | XXXX% | -XXXX% | **1-Year High**: $XXXXXX on 2025-09-30 **1-Year Low**: $XXXXXX on 2024-10-23 ### AltRank: XXXXX [#](/topic/$mdgl/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/alt_rank.tsv) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently AltRank #1,307 based on combined combined social and market metrics **Daily Average**: XXX **1 Week**: XXX +114 **1 Month**: XXXXX +1,225 **6 Months**: XXXXX +298 **1 Year**: XXXXX +679 **1-Year High**: XXXXX on 2025-09-24 **1-Year Low**: X on 2024-11-02 ### Galaxy Score: XXXXX [#](/topic/$mdgl/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX +7 **1 Month**: XX -XX **6 Months**: XX -X **1 Year**: XX -XX **1-Year High**: XX on 2025-02-26 **1-Year Low**: XX on 2024-11-15 ### Engagements: XXXXX [#](/topic/$mdgl/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXXX **1 Week**: XXXXXX -XXXX% **1 Month**: XXXXXXX -XX% **6 Months**: XXXXXXXXX +4.90% **1 Year**: XXXXXXXXXX +30% **1-Year High**: XXXXXXX on 2024-11-01 **1-Year Low**: XXXXX on 2025-04-19 | Social Network | X | | -------------- | - | | Engagements | XXXXX | ### Mentions: XX [#](/topic/$mdgl/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XXX **1 Month**: XXX -XX% **6 Months**: XXXXX -XX% **1 Year**: XXXXXX +253% **1-Year High**: XXXXX on 2025-07-17 **1-Year Low**: XX on 2025-04-03 | Social Network | X | | -------------- | - | | Mentions | XXX | ### Creators: XX [#](/topic/$mdgl/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XXX **1 Month**: XX -XX% **6 Months**: XXXXX +48% **1 Year**: XXXXX +211% **1-Year High**: XXX on 2025-07-17 **1-Year Low**: XX on 2025-10-18 The most influential creators that mention Madrigal Pharmaceuticals, Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@RyshabTalks](/creator/twitter/RyshabTalks) | X | XXXXX | X | XXXXX | | [@seedy19tron](/creator/twitter/seedy19tron) | X | XXXXX | X | XXX | | [@Andre_AGTC](/creator/twitter/Andre_AGTC) | X | XXXXX | X | XXX | | [@BAMBossie81](/creator/twitter/BAMBossie81) | X | XXX | X | XXX | | [@WallStSai](/creator/twitter/WallStSai) | X | XXXXX | X | XXX | | [@JoseRestonVA](/creator/twitter/JoseRestonVA) | X | XXXXX | X | XXX | | [@bioinvestor24](/creator/twitter/bioinvestor24) | X | XXXXX | X | XXX | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X | XXXXX | X | XX | | [@monaco_biotech](/creator/twitter/monaco_biotech) | X | XXXXX | X | XX | | [@PJamess69](/creator/twitter/PJamess69) | XX | XXX | X | XX | [View More](/list/creators/$mdgl/100) ### Sentiment: XX% [#](/topic/$mdgl/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XXX% +25% **1 Month**: XX% -X% **6 Months**: XX% +22% **1 Year**: XX% +14% **1-Year High**: XX% on 2025-09-03 **1-Year Low**: XX% on 2024-10-21 **Most Supportive Themes** - **Potential Acquisition by Big Pharma:** (45%) Madrigal is seen as an attractive acquisition target by big pharma. - **Positive Clinical Data and Market Leadership:** (30%) Positive clinical trial results for Rezdiffra and Madrigal's market leadership in MASH are highlighted. - **Undervalued Stock:** (20%) Many investors believe MDGL is undervalued, suggesting a strong buying opportunity. **Most Critical Themes** - **Price Dip and Market Manipulation:** (5%) The recent price decline is being attributed to profit-taking and potential market manipulation. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXX | XX% | XXXXX | XX% | XXX | XX% | | | | | | | | | | Total | XXXXX | XX% | XXXXX | XX% | XXX | XX% | ### Social Dominance: XXXXXXX% [#](/topic/$mdgl/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/social_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: XXXXX% **1 Week**: XXXXX% +0.04% **1 Month**: XXXXX% -XXXXXXXXXXXXXXXXXXXXX% **6 Months**: XXXXX% -XXXXX% **1 Year**: XXXXX% -XXXXX% **1-Year High**: XXXXX% on 2025-01-24 **1-Year Low**: XXXXXX% on 2025-10-03 ### Market Dominance: XXXXX% [#](/topic/$mdgl/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/market_dominance.tsv) **Current Value**: XXXXX% **Daily Average**: X% **1-Year High**: XXXXX% on 2025-03-25 **1-Year Low**: XXXXXXX% on 2024-10-22 ### Market Cap: $XXXXXXXXXXXXX [#](/topic/$mdgl/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXX +$2% **1 Month**: $XXXXXXXXXXXXX -$0.42% **6 Months**: $XXXXXXXXXXXXX +$49% **1 Year**: $XXXXXXXXXXXXX +$110% **1-Year High**: $XXXXXXXXXXXXXX on 2025-09-30 **1-Year Low**: $XXXXXXXXXXXXX on 2024-10-23 **Top assets mentioned** In the posts about Madrigal Pharmaceuticals, Inc. Common Stock in the last XX hours [Dollar Tree Inc (DLTR)](/topic/dollar-tree-inc) [Dollar Tree Inc (DLTR)](/topic/$dltr) [Akropolis (AKRO)](/topic/$akro) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Novo-Nordisk (NVO)](/topic/$nvo) [Pfizer, Inc. (PFE)](/topic/$pfe) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Insmed, Inc. (INSM)](/topic/$insm) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) **Top topics mentioned** In the posts about Madrigal Pharmaceuticals, Inc. Common Stock in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [stocks consumer defensive](/topic/stocks-consumer-defensive), [dollar tree inc](/topic/dollar-tree-inc), [$dltr](/topic/$dltr), [$iccm](/topic/$iccm), [$akro](/topic/$akro), [$vktx](/topic/$vktx), [$nvo](/topic/$nvo), [$pfe](/topic/$pfe), [stocks technology](/topic/stocks-technology), [$bbio](/topic/$bbio), [$insm](/topic/$insm), [acquisition](/topic/acquisition), [$eem](/topic/$eem), [$bmy](/topic/$bmy), [johnson johnson](/topic/johnson-johnson), [$jnj](/topic/$jnj), [$etnb](/topic/$etnb), [$mrk](/topic/$mrk), [stocks financial services](/topic/stocks-financial-services), [$iva](/topic/$iva), [investment](/topic/investment), [$krys](/topic/$krys), [$rvmd](/topic/$rvmd), [coins dao](/topic/coins-dao), [$spy](/topic/$spy), [$qqq](/topic/$qqq), [coins defi](/topic/coins-defi), [r1 rcm holdco inc](/topic/r1-rcm-holdco-inc), [$rcm](/topic/$rcm), [$tars](/topic/$tars), [$cytk](/topic/$cytk), [$abbv](/topic/$abbv), [$rna](/topic/$rna), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$smmt](/topic/$smmt), [$hood](/topic/$hood), [$pgy](/topic/$pgy), [$adhcon](/topic/$adhcon), [$ions](/topic/$ions), [goldman sachs](/topic/goldman-sachs), [$krtx](/topic/$krtx), [$abvx](/topic/$abvx), [$62b](/topic/$62b), [alt aptoslaunch token](/topic/alt-aptoslaunch-token), [$alt](/topic/$alt), [stocks communication services](/topic/stocks-communication-services), [insider](/topic/insider), [$rytm](/topic/$rytm), [$iwm](/topic/$iwm), [$dave](/topic/$dave), [$alab](/topic/$alab), [united therapeutics corp](/topic/united-therapeutics-corp), [$uthr](/topic/$uthr), [$incy](/topic/$incy), [$mlys](/topic/$mlys), [$xbi](/topic/$xbi), [$pipr](/topic/$pipr), [$crmd](/topic/$crmd), [applovin](/topic/applovin), [momentum](/topic/momentum), [monaco](/topic/monaco), [blockbuster](/topic/blockbuster), [$myok](/topic/$myok), [$rhhby](/topic/$rhhby), [$axsm](/topic/$axsm), [$xene](/topic/$xene), [$imgn](/topic/$imgn), [$apge](/topic/$apge), [$idya](/topic/$idya), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks industrials](/topic/stocks-industrials), [gsk plc](/topic/gsk-plc), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$exel](/topic/$exel), [coins base ecosystem](/topic/coins-base-ecosystem), [$acad](/topic/$acad), [$onc](/topic/$onc), [$ewtx](/topic/$ewtx), [eli lilly](/topic/eli-lilly), [telegram](/topic/telegram), [$bmrn](/topic/$bmrn), [$adhcfda](/topic/$adhcfda), [$adhc](/topic/$adhc), [$adhc0015](/topic/$adhc0015), [wall street](/topic/wall-street), [$srrk](/topic/$srrk), [$mdgls](/topic/$mdgls), [$alec](/topic/$alec), [rating agency](/topic/rating-agency), [$cdtx](/topic/$cdtx), [$ctmx](/topic/$ctmx), [ticker](/topic/ticker), [attention to](/topic/attention-to), [dd](/topic/dd), [investments](/topic/investments), [day of](/topic/day-of), [$psnl](/topic/$psnl), [$7b](/topic/$7b), [$15b](/topic/$15b) ### Top Social Posts [#](/topic/$mdgl/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$UTHR/$EXEL/$MDGL/$SMMT: Four commercial-stage biotechs liked but not owned fully valued today buyable on a real sell-off. Smart money watches catalysts (readouts approvals) cash runway and valuation multiples not PR soundbites. Size like a PM buy the reset not the hype" [X Link](https://x.com/lintrix_x/status/1979608415661064227) [@lintrix_x](/creator/x/lintrix_x) 2025-10-18T18:00Z 2881 followers, XX engagements "Portfolio Update as of Oct XX 2025 🟢 YTD Returns: +77% 🟢 $SPY XX% 🟢 $QQQ XX% 🟢 $IWM X% $DAVE XX% $ALAB XX% $TARS XX% $CRDO XX% $RDDT XX% $ETON X% $HIT X% $MDGL X% $AVDL X% $DCTH X% $CRMD X% $WSTL X% $ZMDTF X% $ACFN X% Portfolio is XXX% long and has XX holdings" [X Link](https://x.com/RyshabTalks/status/1979312695464620355) [@RyshabTalks](/creator/x/RyshabTalks) 2025-10-17T22:24Z 1598 followers, 1635 engagements "@seedy19tron @JoseRestonVA @A_May_MD $MDGL wait for $ALT 48w data Same KOL Nourdinne is/was the lead on their MASH program he is super bullish on Pemv MASH (fast track PH3) My top picks $SNDX PRV PDUFA $WVE 2x data $VNDA 2x PDUFA" [X Link](https://x.com/BAMBossie81/status/1979235596808733057) [@BAMBossie81](/creator/x/BAMBossie81) 2025-10-17T17:18Z XXX followers, XXX engagements "No of course not Jose. I respect you man youve made some great trades for the time Ive followed you. We can be have opposing views but only respect for you as a human. It was more sense checking whether $RNA $MDGL longs think its pulled back enough for re add but I do know you have a longer term horizon with your plays" [X Link](https://x.com/seedy19tron/status/1979231327976329562) [@seedy19tron](/creator/x/seedy19tron) 2025-10-17T17:01Z 8709 followers, 1700 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Truist initiates Madrigal Pharmaceuticals at Buy with a $XXX price target, fueling acquisition speculation and positive sentiment. The stock is experiencing a slight price decline, likely due to profit-taking.
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a biopharmaceutical company focused on therapeutics for non-alcoholic steatohepatitis (NASH).
Madrigal Pharmaceuticals, Inc. Common Stock uses the ticker $MDGL for trading. Listed in the Stocks and category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The current price decline to $XXXXXX is likely due to profit-taking, despite positive sentiment and strong social engagement driven by acquisition rumors and positive news, as the stock is up XXXX% in the last XX hours.
24-Hour | 7-Day | 30-Day |
---|---|---|
-XXXX% | XXXX% | -XXXX% |
1-Year High: $XXXXXX on 2025-09-30
1-Year Low: $XXXXXX on 2024-10-23
AltRank 24-Hour Time-Series Raw Data
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently AltRank #1,307 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +114
1 Month: XXXXX +1,225
6 Months: XXXXX +298
1 Year: XXXXX +679
1-Year High: XXXXX on 2025-09-24
1-Year Low: X on 2024-11-02
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +7
1 Month: XX -XX
6 Months: XX -X
1 Year: XX -XX
1-Year High: XX on 2025-02-26
1-Year Low: XX on 2024-11-15
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XXXX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +4.90%
1 Year: XXXXXXXXXX +30%
1-Year High: XXXXXXX on 2024-11-01
1-Year Low: XXXXX on 2025-04-19
Social Network | X |
---|---|
Engagements | XXXXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX -XX%
1 Year: XXXXXX +253%
1-Year High: XXXXX on 2025-07-17
1-Year Low: XX on 2025-04-03
Social Network | X |
---|---|
Mentions | XXX |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XXX
1 Month: XX -XX%
6 Months: XXXXX +48%
1 Year: XXXXX +211%
1-Year High: XXX on 2025-07-17
1-Year Low: XX on 2025-10-18
The most influential creators that mention Madrigal Pharmaceuticals, Inc. Common Stock in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@RyshabTalks | X | XXXXX | X | XXXXX |
@seedy19tron | X | XXXXX | X | XXX |
@Andre_AGTC | X | XXXXX | X | XXX |
@BAMBossie81 | X | XXX | X | XXX |
@WallStSai | X | XXXXX | X | XXX |
@JoseRestonVA | X | XXXXX | X | XXX |
@bioinvestor24 | X | XXXXX | X | XXX |
@MarcJacksonLA | X | XXXXX | X | XX |
@monaco_biotech | X | XXXXX | X | XX |
@PJamess69 | XX | XXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +25%
1 Month: XX% -X%
6 Months: XX% +22%
1 Year: XX% +14%
1-Year High: XX% on 2025-09-03
1-Year Low: XX% on 2024-10-21
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXXXX | XX% | XXX | XX% |
Total | XXXXX | XX% | XXXXX | XX% | XXX | XX% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.04%
1 Month: XXXXX% -XXXXXXXXXXXXXXXXXXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-24
1-Year Low: XXXXXX% on 2025-10-03
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-25
1-Year Low: XXXXXXX% on 2024-10-22
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$2%
1 Month: $XXXXXXXXXXXXX -$0.42%
6 Months: $XXXXXXXXXXXXX +$49%
1 Year: $XXXXXXXXXXXXX +$110%
1-Year High: $XXXXXXXXXXXXXX on 2025-09-30
1-Year Low: $XXXXXXXXXXXXX on 2024-10-23
Top assets mentioned In the posts about Madrigal Pharmaceuticals, Inc. Common Stock in the last XX hours
Dollar Tree Inc (DLTR) Dollar Tree Inc (DLTR) Akropolis (AKRO) Viking Therapeutics, Inc (VKTX) Novo-Nordisk (NVO) Pfizer, Inc. (PFE) BridgeBio Pharma, Inc. Common Stock (BBIO) Insmed, Inc. (INSM) Bristol-Myers Squibb Co (BMY)
Top topics mentioned In the posts about Madrigal Pharmaceuticals, Inc. Common Stock in the last XX hours
stocks healthcare, stocks consumer defensive, dollar tree inc, $dltr, $iccm, $akro, $vktx, $nvo, $pfe, stocks technology, $bbio, $insm, acquisition, $eem, $bmy, johnson johnson, $jnj, $etnb, $mrk, stocks financial services, $iva, investment, $krys, $rvmd, coins dao, $spy, $qqq, coins defi, r1 rcm holdco inc, $rcm, $tars, $cytk, $abbv, $rna, stocks bitcoin treasuries, $smmt, $hood, $pgy, $adhcon, $ions, goldman sachs, $krtx, $abvx, $62b, alt aptoslaunch token, $alt, stocks communication services, insider, $rytm, $iwm, $dave, $alab, united therapeutics corp, $uthr, $incy, $mlys, $xbi, $pipr, $crmd, applovin, momentum, monaco, blockbuster, $myok, $rhhby, $axsm, $xene, $imgn, $apge, $idya, stocks consumer cyclical, stocks industrials, gsk plc, sarepta therapeutics inc, $exel, coins base ecosystem, $acad, $onc, $ewtx, eli lilly, telegram, $bmrn, $adhcfda, $adhc, $adhc0015, wall street, $srrk, $mdgls, $alec, rating agency, $cdtx, $ctmx, ticker, attention to, dd, investments, day of, $psnl, $7b, $15b
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$UTHR/$EXEL/$MDGL/$SMMT: Four commercial-stage biotechs liked but not owned fully valued today buyable on a real sell-off. Smart money watches catalysts (readouts approvals) cash runway and valuation multiples not PR soundbites. Size like a PM buy the reset not the hype"
X Link @lintrix_x 2025-10-18T18:00Z 2881 followers, XX engagements
"Portfolio Update as of Oct XX 2025 🟢 YTD Returns: +77% 🟢 $SPY XX% 🟢 $QQQ XX% 🟢 $IWM X% $DAVE XX% $ALAB XX% $TARS XX% $CRDO XX% $RDDT XX% $ETON X% $HIT X% $MDGL X% $AVDL X% $DCTH X% $CRMD X% $WSTL X% $ZMDTF X% $ACFN X% Portfolio is XXX% long and has XX holdings"
X Link @RyshabTalks 2025-10-17T22:24Z 1598 followers, 1635 engagements
"@seedy19tron @JoseRestonVA @A_May_MD $MDGL wait for $ALT 48w data Same KOL Nourdinne is/was the lead on their MASH program he is super bullish on Pemv MASH (fast track PH3) My top picks $SNDX PRV PDUFA $WVE 2x data $VNDA 2x PDUFA"
X Link @BAMBossie81 2025-10-17T17:18Z XXX followers, XXX engagements
"No of course not Jose. I respect you man youve made some great trades for the time Ive followed you. We can be have opposing views but only respect for you as a human. It was more sense checking whether $RNA $MDGL longs think its pulled back enough for re add but I do know you have a longer term horizon with your plays"
X Link @seedy19tron 2025-10-17T17:01Z 8709 followers, 1700 engagements
/topic/$mdgl